Cargando…

Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity

BACKGROUND: COVID-19 studies are primarily from the inpatient setting, skewing towards severe disease. Race and comorbidities predict hospitalization, however, ambulatory presentation of milder COVID-19 disease and characteristics associated with progression to severe disease is not well-understood....

Descripción completa

Detalles Bibliográficos
Autores principales: Vaughan, Laura, Veruttipong, Darlene, Shaw, Jonathan G., Levy, Noemie, Edwards, Lauren, Winget, Marcy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794633/
https://www.ncbi.nlm.nih.gov/pubmed/33421991
http://dx.doi.org/10.1186/s12879-021-05764-x
_version_ 1783634255829532672
author Vaughan, Laura
Veruttipong, Darlene
Shaw, Jonathan G.
Levy, Noemie
Edwards, Lauren
Winget, Marcy
author_facet Vaughan, Laura
Veruttipong, Darlene
Shaw, Jonathan G.
Levy, Noemie
Edwards, Lauren
Winget, Marcy
author_sort Vaughan, Laura
collection PubMed
description BACKGROUND: COVID-19 studies are primarily from the inpatient setting, skewing towards severe disease. Race and comorbidities predict hospitalization, however, ambulatory presentation of milder COVID-19 disease and characteristics associated with progression to severe disease is not well-understood. METHODS: We conducted a retrospective chart review including all COVID-19 positive cases from Stanford Health Care (SHC) in March 2020 to assess demographics, comorbidities and symptoms in relationship to: 1) their access point of testing (outpatient, inpatient, and emergency room (ER)) and 2) development of severe disease. RESULTS: Two hundred fifty-seven patients tested positive: 127 (49%), 96 (37%), and 34 (13%) at outpatient, ER and inpatient, respectively. Overall, 61% were age < 55; age > 75 was rarer in outpatient setting (11%) than ER (14%) or inpatient (24%). Most patients presented with cough (86%), fever/chills (76%), or fatigue (63%). 65% of inpatients reported shortness of breath compared to 30–32% of outpatients and ER patients. Ethnic/minority patients had a significantly higher risk of developing severe disease (Asian OR = 4.8 [1.6–14.2], Hispanic OR = 3.6 [1.1–11.9]). Medicare-insured patients were marginally more likely (OR = 4.0 [0.9–17.8]). Other factors associated with developing severe disease included kidney disease (OR = 6.1 [1.0–38.1]), cardiovascular disease (OR = 4.7 [1.0–22.1], shortness of breath (OR = 5.4 [2.3–12.6]) and GI symptoms (OR = 3.3 [1.4–7.7]; hypertension without concomitant CVD or kidney disease was marginally significant (OR = 2.3 [0.8–6.5]). CONCLUSIONS: Early widespread symptomatic testing for COVID-19 in Silicon Valley included many less severely ill patients. Thorough manual review of symptomatology reconfirms the heterogeneity of COVID-19 symptoms, and challenges in using clinical characteristics to predict decline. We re-demonstrate that socio-demographics are consistently associated with severity.
format Online
Article
Text
id pubmed-7794633
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77946332021-01-11 Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity Vaughan, Laura Veruttipong, Darlene Shaw, Jonathan G. Levy, Noemie Edwards, Lauren Winget, Marcy BMC Infect Dis Research Article BACKGROUND: COVID-19 studies are primarily from the inpatient setting, skewing towards severe disease. Race and comorbidities predict hospitalization, however, ambulatory presentation of milder COVID-19 disease and characteristics associated with progression to severe disease is not well-understood. METHODS: We conducted a retrospective chart review including all COVID-19 positive cases from Stanford Health Care (SHC) in March 2020 to assess demographics, comorbidities and symptoms in relationship to: 1) their access point of testing (outpatient, inpatient, and emergency room (ER)) and 2) development of severe disease. RESULTS: Two hundred fifty-seven patients tested positive: 127 (49%), 96 (37%), and 34 (13%) at outpatient, ER and inpatient, respectively. Overall, 61% were age < 55; age > 75 was rarer in outpatient setting (11%) than ER (14%) or inpatient (24%). Most patients presented with cough (86%), fever/chills (76%), or fatigue (63%). 65% of inpatients reported shortness of breath compared to 30–32% of outpatients and ER patients. Ethnic/minority patients had a significantly higher risk of developing severe disease (Asian OR = 4.8 [1.6–14.2], Hispanic OR = 3.6 [1.1–11.9]). Medicare-insured patients were marginally more likely (OR = 4.0 [0.9–17.8]). Other factors associated with developing severe disease included kidney disease (OR = 6.1 [1.0–38.1]), cardiovascular disease (OR = 4.7 [1.0–22.1], shortness of breath (OR = 5.4 [2.3–12.6]) and GI symptoms (OR = 3.3 [1.4–7.7]; hypertension without concomitant CVD or kidney disease was marginally significant (OR = 2.3 [0.8–6.5]). CONCLUSIONS: Early widespread symptomatic testing for COVID-19 in Silicon Valley included many less severely ill patients. Thorough manual review of symptomatology reconfirms the heterogeneity of COVID-19 symptoms, and challenges in using clinical characteristics to predict decline. We re-demonstrate that socio-demographics are consistently associated with severity. BioMed Central 2021-01-09 /pmc/articles/PMC7794633/ /pubmed/33421991 http://dx.doi.org/10.1186/s12879-021-05764-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Vaughan, Laura
Veruttipong, Darlene
Shaw, Jonathan G.
Levy, Noemie
Edwards, Lauren
Winget, Marcy
Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title_full Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title_fullStr Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title_full_unstemmed Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title_short Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity
title_sort relationship of socio-demographics, comorbidities, symptoms and healthcare access with early covid-19 presentation and disease severity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794633/
https://www.ncbi.nlm.nih.gov/pubmed/33421991
http://dx.doi.org/10.1186/s12879-021-05764-x
work_keys_str_mv AT vaughanlaura relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity
AT veruttipongdarlene relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity
AT shawjonathang relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity
AT levynoemie relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity
AT edwardslauren relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity
AT wingetmarcy relationshipofsociodemographicscomorbiditiessymptomsandhealthcareaccesswithearlycovid19presentationanddiseaseseverity